BioArctic AB (publ), a Swedish research-based biopharma company, announced that the first patient has been dosed with exidavnemab in the EXIST phase 2a study, in Parkinson’s disease patients.
The singer, 50, revealed earlier this year that his mother Janet had been diagnosed with dementia, four-years after his ...